The No. 2 U.S. drugmaker on Tuesday said it earned $2.03
billion, or 68 cents per share, in the second quarter.
That compared with $906 million, or 30 cents per share,
in the year-earlier period, when Merck took charges for
acquisitions and restructuring.
items, Merck earned 85 cents per share. Analysts, on
average, were expecting 81 cents per share, according to
Thomson Reuters I/B/E/S.
(Reporting by Ransdell Pierson)